Agreement of Assignment among Shijiazhuang Pharmaceutical Group Corporation, Unigene Laboratories Inc., and China Pharmaceutical Group Limited
Shijiazhuang Pharmaceutical Group Corporation, Unigene Laboratories Inc., and China Pharmaceutical Group Limited have agreed that all rights, responsibilities, and obligations of Shijiazhuang Pharmaceutical Group Corporation under several specified agreements will be fully transferred to China Pharmaceutical Group Limited. China Pharmaceutical Group Limited accepts this transfer without reservation. The agreement is effective immediately upon signature by all parties.
EXHIBIT 10.4
AGREEMENT OF ASSIGNMENT
Party A: Shijiazhuang Pharmaceutical Group Corporation
Party B: Unigene Laboratories Inc.
Party C: China Pharmaceutical Group Limited
It is unanimously agreed between Parties A, B and C to assign all rights, responsibilities and obligations of Party A without reservation to Party C manifested in, including but not limited to, the following documents:
| 1. | Confidentiality Agreement dated October 29, 1998 |
| 2. | Joint Venture Contract dated June 15, 2000 |
| 3. | Articles of Association dated June 15, 2000 |
| 4. | Agreement dated June 9, 2006 |
| 5. | Addendum SPG Unigene Joint Venture dated December 16, 2007 |
| 6. | Technology Transfer Agreement dated April 23, 2008 |
Party C agrees without any reservation to accept such assignment with full legal and business competence as well as full knowledge.
This agreement takes effect immediately upon signature of the three parties.
Signed by:
Party A: Shijiazhuang Pharmaceutical Group Corporation
Representative:
/s/Cai Dongchen
Party B: Unigene Laboratories Inc.
Representative:
/s/Warren P. Levy
Party C: China Pharmaceutical Group Limited
Representative:
/s/Cai Dongchen
Shijiazhuang, Hebei Province, PRC. April 23, 2008
